Femegyl® Intradermal Implant, Sterile

Femegyl® Intradermal Implant, Sterile

According to TU 9398-009-93349853-2015

Variants:

• Femegyl® F1
• Femegyl® F2

Contents:

• Intradermal implant with 2.4% sodium hyaluronate solution in syringe: 0.75 ml, 1.0 ml, 1.25 ml, 1.5 ml
• Instructions for use
• Self-adhesive labels – 2 pcs

Variant:

• Femegyl® M

Contents:

• Intradermal implant with 2.2% sodium hyaluronate solution in syringe: 1.25 ml, 1.5 ml, 1.75 ml, 2.0 ml
• Instructions for use
• Self-adhesive labels – 2 pcs
• Intradermal implant with 2.2% sodium hyaluronate solution in vial: 6.5 ml

Variant:

• Femegyl® R

Contents:

• Intradermal implant with 2.0% sodium hyaluronate solution in syringe: 1.25 ml, 1.5 ml, 1.75 ml, 2.0 ml
• Instructions for use
• Self-adhesive labels – 2 pcs
• Intradermal implant with 2.0% sodium hyaluronate solution in vial: 6.5 ml

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Femegyl® Intradermal Implant, Sterile, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.